Please assess the completion status of the following clinical trial:

Trial Title: Smoking Relapse Prevention Among COPD Ex-smokers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Daily smokers~* Diagnosed with COPD (as per the Global Initiative for Chronic Obstructive Lung Disease \[GOLD\] criteria, namely: a characteristic clinical picture of dyspnea, cough or sputum, with a history of exposure to risk factors, plus a post-bronchodilator forced expiratory volume in one second / forced vital capacity FEV1/FVC ratio of \<0.70)~* Have stable COPD (i.e. no exacerbation, hospital admission, or use of antibiotics or prednisone in the past six weeks)~* Can provide consent~* Reside in the Auckland region of New Zealand~* Eligible under New Zealand special authority to receive subsidised varenicline~* Prepared to make a quit attempt with varenicline~* Have access to a phone~Exclusion Criteria:~* A history of definite asthma and/or atopy~* Contraindications to varenicline~* Used varenicline in the past 12 months~* A history of serious psychiatric illness or significant cognitive impairment~* Major or uncontrolled co-morbidities (such as uncontrolled heart failure, infection or rapidly progressive condition)~* A life expectancy of \< 12 months~* Are currently using another cessation medication (including e-cigarettes)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Varenicline plus behavioural support (Type: ACTIVE_COMPARATOR): 12 weeks extended treatment with varenicline, plus relapse prevention-orientated behavioural support
- Placebo plus behavioural support (Type: PLACEBO_COMPARATOR): 12 weeks extended treatment with placebo, plus relapse prevention-orientated behavioural support

Based on this trial design, predict the completion outcome and termination type (if applicable).